Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By End Use
2.3.2 Market Size By Application
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Pricing Analysis & Forecast
4.1.1 Overview
4.1.2 Pricing Analysis & Forecast By End Use, 2021–2032
4.1.3 Price Benchmarking By Key Players, 2024
4.2 Regulatory Landscape
4.2.1 Overview
4.2.2 Regulatory Trends By Key Countries
4.2.3 Regulatory Outlook By End Use Type
4.3 Trade Analysis
4.3.1 Overview
4.3.2 Import Analysis (Value & Volume), By Country, 2021–2024
4.3.3 Export Analysis (Value & Volume), By Country, 2021–2024
4.3.4 Major Importing Countries
4.3.5 Major Exporting Countries
5. Digital Therapeutics Market Segmental Analysis & Forecast, By End Use, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Patients
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Providers
5.4 Payers
5.5 Employers
5.6 Others
6. Digital Therapeutics Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Diabetes
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Obesity
6.4 CVD
6.5 Respiratory Diseases
6.6 Smoking Cessation
6.7 CNS Diseases
6.8 Others
7. Digital Therapeutics Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
7.1 Introduction
7.2 North America
7.2.1 Key Trends
7.2.2 Digital Therapeutics Market Size & Forecast, By End Use, 2021 – 2032
7.2.3 Digital Therapeutics Market Size & Forecast, By Application, 2021 – 2032
7.2.4 Digital Therapeutics Market Size & Forecast, By Country, 2021 – 2032
7.2.4.1 USA
7.2.4.2 Canada
7.3 Europe
7.3.1 Key Trends
7.3.2 Digital Therapeutics Market Size & Forecast, By End Use, 2021 – 2032
7.3.3 Digital Therapeutics Market Size & Forecast, By Application, 2021 – 2032
7.3.4 Digital Therapeutics Market Size & Forecast, By Country, 2021 – 2032
7.3.4.1 Germany
7.3.4.2 UK
7.3.4.3 France
7.3.4.4 Italy
7.3.4.5 Spain
7.3.4.6 Russia
7.3.4.7 Poland
7.3.4.8 Rest of Europe
7.4 Asia-Pacific
7.4.1 Key Trends
7.4.2 Digital Therapeutics Market Size & Forecast, By End Use, 2021 – 2032
7.4.3 Digital Therapeutics Market Size & Forecast, By Application, 2021 – 2032
7.4.4 Digital Therapeutics Market Size & Forecast, By Country, 2021 – 2032
7.4.4.1 China
7.4.4.2 India
7.4.4.3 Japan
7.4.4.4 South Korea
7.4.4.5 Australia
7.4.4.6 ASEAN Countries
7.4.4.7 Rest of Asia-Pacific
7.5 Latin America
7.5.1 Key Trends
7.5.2 Digital Therapeutics Market Size & Forecast, By End Use, 2021 – 2032
7.5.3 Digital Therapeutics Market Size & Forecast, By Application, 2021 – 2032
7.5.4 Digital Therapeutics Market Size & Forecast, By Country, 2021 – 2032
7.5.4.1 Brazil
7.5.4.2 Argentina
7.5.4.3 Mexico
7.5.4.4 Colombia
7.5.4.5 Rest of Latin America
7.6 Middle East & Africa
7.6.1 Key Trends
7.6.2 Digital Therapeutics Market Size & Forecast, By End Use, 2021 – 2032
7.6.3 Digital Therapeutics Market Size & Forecast, By Application, 2021 – 2032
7.6.4 Digital Therapeutics Market Size & Forecast, By Country, 2021 – 2032
7.6.4.1 UAE
7.6.4.2 Saudi Arabia
7.6.4.3 Qatar
7.6.4.4 South Africa
7.6.4.5 Rest of Middle East & Africa
8. Competitive Landscape
8.1 Key Players' Positioning
8.2 Competitive Developments
8.2.1 Key Strategies Adopted (%), By Key Players, 2024
8.2.2 Year-Wise Strategies & Development, 2021 – 2025
8.2.3 Number Of Strategies Adopted By Key Players, 2024
8.3 Market Share Analysis, 2024
8.4 Product/Service & Application Benchmarking
8.4.1 Product/Service Specifications & Features By Key Players
8.4.2 Product/Service Heatmap By Key Players
8.4.3 Application Heatmap By Key Players
8.5 Industry Start-Up & Innovation Landscape
8.6 Key Company Profiles
8.6.1 OMADA HEALTH, INC.
8.6.1.1 Company Overview & Snapshot
8.6.1.2 Product/Service Portfolio
8.6.1.3 Key Company Financials
8.6.1.4 SWOT Analysis
8.6.2 Welldoc, Inc.
8.6.3 2Morrow, Inc
8.6.4 Livongo Health, Inc. (Teladoc Health, Inc.)
8.6.5 Propeller Health (ResMed)
8.6.6 Fitbit LLC
8.6.7 Mango Health
8.6.8 Jogohealth
8.6.9 CureApp, Inc.
8.6.10 Brain+ A/S
8.6.11 CANARY HEALTH
8.6.12 Noom, Inc.
8.6.13 Pear Therapeutics, Inc.
8.6.14 Akili Interactive Labs, Inc.
8.6.15 HYGIEIA
8.6.16 DarioHealth Corp.
8.6.17 BigHealth
8.6.18 GAIA AG
8.6.19 Limbix Health, Inc.
8.6.20 Kaia Health, Inc.
9. Analyst Recommendations
9.1 SNS Insider Opportunity Map
9.2 Industry Low-Hanging Fruit Assessment
9.3 Market Entry & Growth Strategy
9.4 Analyst Viewpoint & Suggestions On Market Growth
10. Assumptions
11. Disclaimer
12. Appendix
12.1 List Of Tables
12.2 List Of Figures
